NCT00540150View on ClinicalTrials.gov

Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

March 31, 2005

Conditions
Immunotherapy
Interventions
BIOLOGICAL

specific subcutaneous immunotherapy house dust mite allergoid (Novo-Helisen Depot)

We treat each patient with mite-allergen following the two different protocols.

Trial Locations (1)

60590

Goethe University, Department of Pulmonology, Frankfurt am Main

All Listed Sponsors
collaborator

Allergopharma GmbH & Co. KG

INDUSTRY

lead

Johann Wolfgang Goethe University Hospital

OTHER

NCT00540150 - Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy | Biotech Hunter | Biotech Hunter